ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/05/16 | 1,731 | 1,776 | 1,719 | 1,774 | +65 | +3.8% | 128,500 |
| 2017/05/15 | 1,732 | 1,737 | 1,701 | 1,709 | -48 | -2.7% | 125,800 |
| 2017/05/12 | 1,757 | 1,766 | 1,740 | 1,757 | -16 | -0.9% | 59,400 |
| 2017/05/11 | 1,779 | 1,779 | 1,760 | 1,773 | -1 | -0.1% | 67,200 |
| 2017/05/10 | 1,770 | 1,779 | 1,751 | 1,774 | -6 | -0.3% | 72,900 |
| 2017/05/09 | 1,757 | 1,780 | 1,751 | 1,780 | +29 | +1.7% | 94,300 |
| 2017/05/08 | 1,728 | 1,761 | 1,727 | 1,751 | +39 | +2.3% | 157,800 |
| 2017/05/02 | 1,696 | 1,715 | 1,692 | 1,712 | +22 | +1.3% | 90,800 |
| 2017/05/01 | 1,677 | 1,690 | 1,653 | 1,690 | +16 | +1% | 75,200 |
| 2017/04/28 | 1,700 | 1,706 | 1,673 | 1,674 | -17 | -1% | 96,700 |
| 2017/04/27 | 1,690 | 1,696 | 1,679 | 1,691 | -2 | -0.1% | 93,800 |
| 2017/04/26 | 1,703 | 1,703 | 1,681 | 1,693 | +6 | +0.4% | 53,600 |
| 2017/04/25 | 1,685 | 1,695 | 1,677 | 1,687 | +3 | +0.2% | 47,700 |
| 2017/04/24 | 1,681 | 1,691 | 1,677 | 1,684 | +22 | +1.3% | 58,600 |
| 2017/04/21 | 1,655 | 1,666 | 1,649 | 1,662 | +5 | +0.3% | 71,900 |
| 2017/04/20 | 1,641 | 1,665 | 1,631 | 1,657 | +13 | +0.8% | 123,200 |
| 2017/04/19 | 1,636 | 1,653 | 1,635 | 1,644 | -4 | -0.2% | 123,100 |
| 2017/04/18 | 1,660 | 1,663 | 1,646 | 1,648 | +1 | +0.1% | 50,500 |
| 2017/04/17 | 1,621 | 1,656 | 1,621 | 1,647 | +15 | +0.9% | 55,100 |
| 2017/04/14 | 1,653 | 1,655 | 1,629 | 1,632 | -31 | -1.9% | 54,300 |
| 2017/04/13 | 1,660 | 1,671 | 1,648 | 1,663 | -9 | -0.5% | 82,300 |
| 2017/04/12 | 1,680 | 1,682 | 1,667 | 1,672 | -18 | -1.1% | 55,300 |
| 2017/04/11 | 1,682 | 1,700 | 1,682 | 1,690 | -3 | -0.2% | 55,900 |
| 2017/04/10 | 1,715 | 1,715 | 1,690 | 1,693 | +1 | +0.1% | 45,200 |
| 2017/04/07 | 1,701 | 1,712 | 1,689 | 1,692 | -5 | -0.3% | 84,700 |
| 2017/04/06 | 1,733 | 1,746 | 1,694 | 1,697 | -40 | -2.3% | 73,000 |
| 2017/04/05 | 1,744 | 1,757 | 1,716 | 1,737 | -7 | -0.4% | 72,200 |
| 2017/04/04 | 1,746 | 1,763 | 1,734 | 1,744 | -16 | -0.9% | 71,800 |
| 2017/04/03 | 1,780 | 1,780 | 1,732 | 1,760 | +48 | +2.8% | 69,600 |
| 2017/03/31 | 1,766 | 1,767 | 1,712 | 1,712 | -46 | -2.6% | 80,300 |
| 2017/03/30 | 1,808 | 1,816 | 1,756 | 1,758 | -53 | -2.9% | 57,600 |
| 2017/03/29 | 1,805 | 1,816 | 1,792 | 1,811 | -15 | -0.8% | 75,400 |
| 2017/03/28 | 1,802 | 1,827 | 1,792 | 1,826 | +59 | +3.3% | 158,700 |
| 2017/03/27 | 1,762 | 1,781 | 1,762 | 1,767 | -12 | -0.7% | 81,500 |
| 2017/03/24 | 1,772 | 1,782 | 1,759 | 1,779 | +11 | +0.6% | 76,800 |
| 2017/03/23 | 1,780 | 1,787 | 1,762 | 1,768 | -16 | -0.9% | 84,800 |
| 2017/03/22 | 1,799 | 1,799 | 1,782 | 1,784 | -17 | -0.9% | 86,200 |
| 2017/03/21 | 1,803 | 1,808 | 1,796 | 1,801 | -15 | -0.8% | 53,400 |
| 2017/03/17 | 1,819 | 1,819 | 1,807 | 1,816 | -7 | -0.4% | 71,600 |
| 2017/03/16 | 1,802 | 1,825 | 1,796 | 1,823 | +19 | +1.1% | 77,500 |
| 2017/03/15 | 1,816 | 1,816 | 1,800 | 1,804 | -14 | -0.8% | 46,400 |
| 2017/03/14 | 1,820 | 1,822 | 1,809 | 1,818 | +1 | +0.1% | 49,100 |
| 2017/03/13 | 1,807 | 1,823 | 1,807 | 1,817 | +10 | +0.6% | 64,800 |
| 2017/03/10 | 1,806 | 1,815 | 1,795 | 1,807 | +18 | +1% | 113,500 |
| 2017/03/09 | 1,787 | 1,789 | 1,772 | 1,789 | +5 | +0.3% | 41,500 |
| 2017/03/08 | 1,778 | 1,790 | 1,774 | 1,784 | -7 | -0.4% | 42,200 |
| 2017/03/07 | 1,783 | 1,792 | 1,775 | 1,791 | +4 | +0.2% | 37,400 |
| 2017/03/06 | 1,796 | 1,796 | 1,782 | 1,787 | -8 | -0.4% | 35,500 |
| 2017/03/03 | 1,800 | 1,802 | 1,787 | 1,795 | -6 | -0.3% | 52,300 |
| 2017/03/02 | 1,798 | 1,817 | 1,790 | 1,801 | +23 | +1.3% | 110,100 |
1951～
2000
件表示中 / 3696件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 217,100円 | +3.1% | -6.5% | 2.21% | 10.08倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 東和薬品 | 262,400円 | +13.9% | +6.6% | 2.67% | 6.84倍 | 0.81倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ジーエヌアイ | 246,900円 | +21.7% | +999.9% | 0.00% | 10.29倍 | 3.40倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 持田薬 | 309,500円 | +3.0% | +27.5% | 2.58% | 19.59倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 147,400円 | +8.8% | +99.9% | 3.53% | 9.41倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
